Skip to main content

This week at Unbreaking, November 13

As of yesterday, the longest-ever shutdown of the federal government has ended. We’ll be updating our timelines and explainers as the implications of this resolution become clear for all the issues we cover.

What we know for now is that Democrats achieved no measurable progress toward the restoration of affordable healthcare. The massive cuts to Medicaid that the GOP-controlled Congress pushed through this summer are all scheduled to go into effect, and things look bleak for the millions of people in the US whose ACA marketplace coverage will more than double in price. Our Medicaid explainer covers the knowable details for those who rely on Medicaid coverage — about one fifth of the US population.

Unrelated to healthcare coverage but very related to basic health and well-being, we spent time this week looking at federal food safety oversight and how it’s getting worse.

If you’ve seen recent coverage of the deadly ongoing Listeria outbreak associated with prepared pasta, the botulism contamination in baby formula, or the high salmonella levels in grocery-store chicken, you may have wondered if these events are related to Trump administration changes at the CDC, FDA, and USDA. We wish we knew, too. In the short term, it’s nearly impossible to draw causal connections between outbreaks of food poisoning and government actions. But we’ve already seen worrying disruptions:

COUNTERMOVES: Across the issues we track, we’ve seen state and local governments step up as the Trump administration cuts and weaponizes federal services. As federal regulatory enforcement dwindles, state laws are also becoming even more important: Reuters reports that more firms are filing class action suits grounded in state consumer protection laws.

We cover these events and many more in our Food Safety timeline and explainer.

RESEARCH ALERT: Our food safety team has a question: How are food recalls being affected by layoffs and by the long shutdown that just ended? The data is out there — is anyone looking into it? We’ve reached out to reporters but haven’t located an existing investigation into this question.

Use our stuff

We invite everyone to use and adapt our content for sharing with your readers and communities: everything on our site is available under a CC BY 4.0 license. We welcome translations, adaptations to other formats, and especially encourage organizers and journalists to make use of what we’ve developed. And if you make something with our content, please let us know — we’d love to hear from you.

Current page